Trident Texofab Ltd Price Performance
- Day's Low
- ₹0
- Day's High
- ₹0
₹ 0
- 52-w low
- ₹0
- 52-w high
- ₹0
0
- Day's open
₹0 - Previous close
₹0 - VWAP
₹0 - Lower price band
₹0 - Upper price band
₹0
Today's Market Action
Its last traded stock price on BSE was 175.00 up by 1.36%. The total volume of shares on NSE and BSE combined was 17,585 shares. Its total combined turnover was Rs 0.30 crores.
Trident Texofab Ltd Medium and Long Term Market Action
The stock price of Trident Texofab Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.
Trident Texofab Ltd Fundamentals
-
Market Cap (Cr): 102
-
Book Value (₹):
-
Stock P/E:
-
Revenue (Cr):
-
Total Debt (Cr):
-
Face Value (₹):
-
Roce (%):
-
ROE (%):
-
Earnings (Cr):
-
Promoter’s Holdings (%):
-
EPS (₹):
-
Debt to Equity:
-
Dividend Yield (%):
-
Cash (Cr):
Trident Texofab Ltd Mutual fund holdings and trends
FUND NAME | Quantity | Monthly Change (Qty) |
---|
Similar Stocks
Company | Price | Market Cap (Cr) | P/E |
---|
About Trident Texofab Ltd
Data not available.
Trident Texofab Ltd FAQ's
What is Share Price of Trident Texofab Ltd?
What is the Market Cap of Trident Texofab Ltd?
What is PE Ratio of Trident Texofab Ltd?
What is PB Ratio of Trident Texofab Ltd?
What is the CAGR of Trident Texofab Ltd?
How to Buy Trident Texofab Ltd Share?
Financials
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Cash Flow)
Standalone Financial Performace In Graph(Cash Flow)
News
Review
Pros
- No Data Available
Cons
Low Sustainable RoE
Low Return on Capital Employed
Poor Cash Flow Conversion
Low Interest Coverage
Highly Cyclical Industry
Low Pricing Power & High Competition
High Debt
Poor Capital Allocation
Poor Working Capital Cycle
Valuation Analysis
Margin of safety
(10/03/2025)
(10/03/2025)


98
87.50% People are bullish about Trident Texofab Ltd
12.50 % People are bearish about Trident Texofab Ltd